Sensitivity of the NIH Toolbox to Stimulant Treatment in Intellectual Disabilities
Launched by UNIVERSITY OF CALIFORNIA, DAVIS · Mar 17, 2022
Trial Information
Current as of July 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • IQ below 80
- • Mental age 3.0 or higher (Stanford Binet)
- • Diagnosis of Intellectual Disability
- • Diagnosis of ADHD
- • Ability to complete valid NIHTB-CB tests at screening/baseline
- Exclusion Criteria:
- • stimulant use within 2 weeks prior to randomization
- • history of a sensitivity reaction to stimulants
- • presence of significant comorbid psychiatric or medical disorder/illness deemed by the site physician as inappropriate for stimulant use (uncontrolled epilepsy, bipolar disorder, psychosis, severe OCD, hypertension, tachycardia hypertension, failure to thrive, psychosis for example)
- • a household resident with a current substance abuse disorder
About University Of California, Davis
The University of California, Davis (UC Davis) is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials and studies. With a strong focus on interdisciplinary collaboration, UC Davis leverages its extensive expertise in medical research, education, and patient care to drive breakthroughs in various fields, including medicine, public health, and agriculture. The university's clinical trial programs emphasize rigorous scientific methodology and ethical standards, aiming to translate research findings into impactful treatments and improved patient outcomes. Through its state-of-the-art facilities and a dedicated team of researchers and healthcare professionals, UC Davis is at the forefront of transforming healthcare practices and addressing critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Cincinnati, Ohio, United States
Sacramento, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials